Literature DB >> 15634876

Cutting edge: species-specific TLR9-mediated recognition of CpG and non-CpG phosphorothioate-modified oligonucleotides.

Tara L Roberts1, Matthew J Sweet, David A Hume, Katryn J Stacey.   

Abstract

Different DNA motifs are required for optimal stimulation of mouse and human immune cells by CpG oligodeoxynucleotides (ODN). These species differences presumably reflect sequence differences in TLR9, the CpG DNA receptor. In this study, we show that this sequence specificity is restricted to phosphorothioate (PS)-modified ODN and is not observed when a natural phosphodiester backbone is used. Thus, human and mouse cells have not evolved to recognize different CpG motifs in natural DNA. Nonoptimal PS-ODN (i.e., mouse CpG motif on human cells and vice versa) gave delayed and less sustained phosphorylation of p38 MAPK than optimal motifs. When the CpG dinucleotide was inverted to GC in each ODN, some residual activity of the PS-ODN was retained in a species-specific, TLR-9-dependent manner. Thus, TLR9 may be responsible for mediating many published CpG-independent responses to PS-ODN.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15634876     DOI: 10.4049/jimmunol.174.2.605

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  30 in total

1.  Transdermal immunization using solid-in-oil nanodispersion with CpG oligodeoxynucleotide adjuvants.

Authors:  Momoko Kitaoka; Ayaka Naritomi; Yuya Hirakawa; Noriho Kamiya; Masahiro Goto
Journal:  Pharm Res       Date:  2014-11-01       Impact factor: 4.200

2.  Hybrid Mouse Diversity Panel Identifies Genetic Architecture Associated with the Acute Antisense Oligonucleotide-Mediated Inflammatory Response to a 2'-O-Methoxyethyl Antisense Oligonucleotide.

Authors:  Elaine Pirie; Patrick Cauntay; Wuxia Fu; Shayoni Ray; Calvin Pan; Aldonis J Lusis; Jill Hsiao; Sebastien A Burel; Padma Narayanan; Rosanne M Crooke; Richard G Lee
Journal:  Nucleic Acid Ther       Date:  2019-08-01       Impact factor: 5.486

3.  The discovery of potent immunostimulatory CpG-ODNs widely distributed in bacterial genomes.

Authors:  Juan Liu; Yan Wei; Yongling Lu; Yangyuling Li; Qian Chen; Yan Li
Journal:  J Microbiol       Date:  2019-12-23       Impact factor: 3.422

4.  Attenuated activation of macrophage TLR9 by DNA from virulent mycobacteria.

Authors:  Alexandra K Kiemer; Ryan H Senaratne; Jessica Hoppstädter; Britta Diesel; Lee W Riley; Koichi Tabeta; Stefan Bauer; Bruce Beutler; Bruce L Zuraw
Journal:  J Innate Immun       Date:  2008-07-02       Impact factor: 7.349

5.  Topical CpG adjuvantation of a protein-based vaccine induces protective immunity to Listeria monocytogenes.

Authors:  Wing Ki Cheng; Kathleen Wee; Tobias R Kollmann; Jan P Dutz
Journal:  Clin Vaccine Immunol       Date:  2014-01-03

Review 6.  Traditional biochemical assays for studying toll-like receptor 9.

Authors:  Cynthia A Leifer; William A Rose; Fernando Botelho
Journal:  J Immunoassay Immunochem       Date:  2013

Review 7.  Knocking down disease: a progress report on siRNA therapeutics.

Authors:  Anders Wittrup; Judy Lieberman
Journal:  Nat Rev Genet       Date:  2015-09       Impact factor: 53.242

8.  The significance of TNFAIP8 in prostate cancer response to radiation and docetaxel and disease recurrence.

Authors:  Chuanbo Zhang; Bhaskar V Kallakury; Jeffrey S Ross; Rajshree R Mewani; Christine E Sheehan; Isamu Sakabe; George Luta; Deepak Kumar; Sivaramakrishna Yadavalli; Joshua Starr; Taduru L Sreenath; Shiv Srivastava; Harvey B Pollard; Ofer Eidelman; Meera Srivastava; Usha N Kasid
Journal:  Int J Cancer       Date:  2013-01-10       Impact factor: 7.396

9.  Immunogenicity of intrathecal plasmid gene delivery: cytokine release and effects on transgene expression.

Authors:  Travis S Hughes; Stephen J Langer; Salla I Virtanen; Raymond A Chavez; Linda R Watkins; Erin D Milligan; Leslie A Leinwand
Journal:  J Gene Med       Date:  2009-09       Impact factor: 4.565

10.  CpG oligodeoxynucleotides induce cyclooxygenase-2 in human B lymphocytes: implications for adjuvant activity and antibody production.

Authors:  Matthew P Bernard; Richard P Phipps
Journal:  Clin Immunol       Date:  2007-08-28       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.